Quantinuum (QNT) investor relations material

Company overview and business model

• Operates a vertically integrated quantum computing platform, combining proprietary hardware, middleware, and application software for hybrid quantum-classical workflows.

• Focuses on high-fidelity trapped-ion quantum systems using QCCD architecture, with a roadmap toward fault-tolerant quantum computing.

• Monetizes through hardware access (on-premises and cloud), software licensing, research/application development services, and outcome-oriented IP.

• Key markets include pharmaceuticals, materials science, finance, government, and industrial sectors, with strategic partnerships and early customer deployments.

• Formed in 2021 via the combination of Honeywell Quantum Solutions and Cambridge Quantum, leveraging Honeywell’s infrastructure and supply chain.

Financial performance and metrics

• Net revenue for the year ended December 31, 2025: $30.9 million; net loss: $192.6 million.

• Net revenue for the three months ended March 31, 2026: $5.2 million; net loss: $136.6 million.

• Bookings for the year ended December 31, 2025: $79.3 million; bookings for the three months ended March 31, 2026: $1.3 million.

• Cash and cash equivalents as of March 31, 2026: $677.0 million.

• Adjusted EBITDA for the year ended December 31, 2025: $(171.2) million.

Use of proceeds and capital allocation

• Net proceeds from the IPO will be used to purchase newly issued Common Units from Quantinuum Holdings at the IPO price per unit, less underwriting discounts and commissions.

• Quantinuum Holdings will use proceeds for general corporate purposes and to pay offering expenses.

• A portion of proceeds may be allocated to potential acquisitions or investments in complementary technologies or businesses.